newsfilter
← Latest News
GlobeNewswire·

Galecto to Present Poster at Upcoming ATS 2023 International Conference

BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company and world leader in galectin biology focused on the development of novel treatments for fibrosis and cancer,